Exercise Programs Lowered the Risk of Death for People With Cancer

CATEGORY: EXERCISE & MOVEMENT

Advice to stay active is standard in cancer care. Whether it lengthens lives has been much harder to pin down. Pooling 13 randomized trials covering 3,282 people with breast, lung, blood and several other cancers, researchers found that patients put into structured exercise programs were 26% less likely to die of any cause than patients given usual care.¹

Why Thirteen Trials Had to Be Read Together

A single exercise trial runs into hard arithmetic. Measuring survival takes years, and, thankfully, most trials record too few deaths to answer the question alone. The review, published in Cancer Treatment Reviews, got around that by gathering every eligible trial in which patients were allocated at random to an exercise program or to usual care. That random allocation is what separates this evidence from the many studies that simply observe that active patients fare better. Those can never rule out that patients well enough to exercise were healthier to begin with. Here, only the exercise differed by design.¹

From Brisk Walks to Dumbbells, Two Weeks to Three Years

The 13 trials enrolled 3,282 patients with breast, lung, blood, ovarian, esophageal and colorectal disease among others. Some programs tested aerobic exercise, meaning steady movement that lifts the heart rate, as ordinary as a brisk walk or a bike ride. Others tested resistance training, working the muscles against a load, like curling a dumbbell up slowly and letting it back down. Some combined the two. Programs ran anywhere from two weeks to three years, and the trials then followed participants for up to ten years, counting deaths from any cause.¹

Length of Program Did Not Change the Answer

Pooled, the trials showed a 26% lower risk of death among patients assigned to exercise, which the reviewers rated moderate-certainty evidence, with individual trials landing notably close to one another. Program length barely mattered. The reduction looked much the same in shorter and longer programs, and much the same whether or not the cancer was a hormone-dependent type such as breast cancer. The benefit was not riding on one patient type. The authors suggest exercise may work through several routes at once, among them effects on insulin (the hormone that controls blood sugar), on inflammation, and on the immune system’s ongoing patrol for abnormal cells. The largest single trial in the field points the same way. In it, 889 colon cancer patients who had finished surgery and chemotherapy were allocated to a three-year coached exercise program or to health-education booklets; over roughly eight years the exercisers were 37% less likely to die, with 90.3% alive at eight years versus 83.2%.² Observational data pooled from 151 patient groups, about 1.5 million people with cancer, found lower death rates among those who stayed active after diagnosis, about 31% lower in breast cancer, though studies of that kind show association rather than cause.³

Key Takeaways

• Structured exercise programs, aerobic or resistance or both, cut the risk of death from any cause by 26% compared with usual care, across 13 randomized trials of 3,282 people with cancer.
• Random allocation to exercise is what gives the pooled result causal weight that observational studies of active patients cannot carry.
• The benefit looked similar across shorter and longer programs and across the cancer types studied, and it lines up with the largest single trial, in which colon cancer patients in a coached program were 37% less likely to die over eight years.

References

1. Guillermou H, Diallo A, Rathat G, Galtier F. Physical activity reduces all-cause mortality in patients with cancer: a systematic review and meta-analysis of randomized controlled trials. Cancer Treatment Reviews. 2026;145:103122. link
2. Courneya KS, Vardy JL, O’Callaghan CJ, et al. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. New England Journal of Medicine. 2025;393(1):13–25. link
3. Ungvari Z, Fekete M, Varga P, et al. Exercise and survival benefit in cancer patients: evidence from a comprehensive meta-analysis. GeroScience. 2025;47(3):5235–5255. link